The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd

DOCON TECHNOLOGIES PRIVATE LIMITED August 13, 2026 To, To, National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Phiroze Jeejeebhoy Towers, Block G, Bandra Kurla Complex, Dalal Street, Mumbai-400001 Bandra {E), Mumbai-400051 Thyrocare Technologies Limited D37/3, TTC MIDC, Turbhe, Navi Mumbai-400 073 Sub: Disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers Re ulations 2011 - Sale of 1,57 69 696 Equit Shares of Th rocare Technologies Limited by Promoter We hereby inform you that Docon Technologies Private Limited {"Docon"), a wholly owned subsidiary of API Holdings Limited {"API") and a Promoter & Holding Company of Thyrocare Technologies Limited {"Thyrocare"), which was holding 60.92% of the total equity share capital of Thyrocare, has sold 1,57,69,696 equity shares, representing approximately 9.9% of the total paid up share capital of Thyrocare. Pursuant to the requirements of Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, we enclose herewith the necessary disclosure in the prescribed format as Annexure I. Following the aforesaid transaction, Docon continues to remain the Promoter & Holding Company of the Thyrocare. Post this aforesaid sale, the promoter shareholding in Thyrocare has been reduced from 60.92% to 51.02% of the total paid-up equity share capital. You are requested to take the same on record. For Docon Technologies Private Limited hur- Sudhir Sarangdhar ~... -? i Company Secretary CIN No: U72900MH2016PTC443000 Registered Office: D37/ 3, TIC Industrial Area, MIDC, Turbhe, Navi Mumbai, Thane, Maharashtra, India, 400703 Email Id: corporat:esecretarial@docon.co.i.n I Telephone No.: 06364926900 DOCON TECHNOLOGIES PRIVATE LIMITED Annexure I Disclosures under Regulation 29(2) of Securities and Exchange Board of India {Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Name of the Target Company(TC) Thyrocare Technologies Limited ('Thyrocare") Name(s) of the acquirer and Persons Acting in Acquirer: #Docon Technologies Private Limited Concert (PAC) with the acquirer (The Acquirer has not acquired any additional shares. This disclosure is being made solely to inform stakeholders about the disposal of shares related to Thyrocare Technologies Limited) Whether the acquirer belongs to Yes Promoter/Promoter group Name(s) of the Stock Exchange(s) where the 1. BSE Limited shares ofTC are Listed 2. National Stock Exchange of India Limited Details of the acquisition/ disposal as follows Number % w.r.t. total o/ow.r.t. share /voting total capital wherever diluted applicable(*) share/votin gcapitalof the TC(**) Before the acquisition under consideration, holding of: a. Shares carrying voting rights 1,75,00,000 10.99 10.96 b. Shares in the nature of encumbrance 7,94,69,696 49.93 49.79 (pledge, ,:~ ., ,~ ~ '-" ''-"'-'1 ............ • 0 . eH,efs) c. Voting rights (VR) otherwise than by NIL NIL NIL shares d. Warrants/convertible securities/any NIL NIL NIL other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) e. Total (a+b+c+d) 9,69,69,696 60.92 60.75 Details of aeqttisitionfsale a. Shares carrying voting rights 1,57,69,696 9.90 9.88 aeeit:1ifed/sold b. VRs acquired /sold otherwise than by NIL NIL NIL shares C. Warrants/convertible securities/any NIL NIL NIL other CIN No: U72900MH2016PTC443000 Registered Office: D37 /3, TIC Industrial Area, MIDC, Turbhe, Navi Mumbai, Thane, Maharashtra, India, 400703 Email Id: corporatesecretarial@docon.co.i.n I Telephone No.: 06364926900 DOCON TECHNOLOGIES PRIVATE LIMITED d. instrument that entitles the acquirer to NIL NIL NIL receive shares carrying voting rights in the TC {speeify l'leldiflg ifl eael'l eategery} aeqt:1ifedfseld Sl'lafes eF1et:1mt:lefed f iflvel<'edffeleased by tl'le aeqt:1iFeF) e. Total (a+b+c+/-d) 1,57, 69,696 9.90 9.88 After the aequisitionfsale, holding of: a. Shares carrying voting rights 17,30,304 1.09 1.08 b. #Shares encumbered with the aeqt:1ifef 7,94,69,696 49.93 49.79 C. VRs otherwise than by shares NIL NIL NIL d. Warrants/convertible securities/any NIL NIL NIL other instrument that entitles the acquirerto receive shares carrying voting rights in the TC (specify holding in each category) after acquisition e. Total (a+b+c+d} 8, 12,00,000 51.02 50.87 Mode of aeqt:1isitieF1 f sale (e.g. open market/ Sale of 1,57,69,696 equity shares of Thyrocare off-market I public issue/ rights issue/ rT" echnologies Limited on market trades preferential allotment I inter-se transfer etc). (including block deals) Date of aeqt:1isitieF1 f sale of shares f VR ef date August 13, 2026. ef rneeipt ef iF1tiffiatieF1 ef aHetmeflt ef sl'larns, whichever is applicable Equity share capital/ total voting capital of the 15,91,65,315 Equity shares having face value of TC before the said acquisition/ sale Rs. 10 each Equity share capital/ total voting capital of the 15,91,65,315 Equity shares having face value of TC after the said acquisition/ sale Rs. 10 each Total diluted share/voting capital of the TC after 15,96,30,252 equity shares having face value the said acquisition of Rs. 10 each (*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the listing Agreement. (**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC. #The Acquirer has not acquired any additional shares. This disclosure is being made solely to inform stakeholders about the disposal of shares related to Thyrocare Technologies Limited. For and on beha~ of Docon Technologies Private Limited Madhuri Sudhir Sarangdhar ~ Company Secretary Date:August13,2026 CIN No: U72900MH2016PTC443000 Registered Office: D37/ 3, TIC Industrial Area, MIDC, Turbhe, Navi Mumbai, Thane, Maharashtra, India, 400703 Email Id: corporatesecretarial@docon.co.i.n I Telephone No.: 06364926900